{"id":344,"date":"2024-09-13T15:02:29","date_gmt":"2024-09-13T13:02:29","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/"},"modified":"2024-09-13T15:02:41","modified_gmt":"2024-09-13T13:02:41","slug":"loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/","title":{"rendered":"L&rsquo;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/who-grants-first-mpox.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2024\/who-grants-first-mpox.jpg\" data-sub-html=\"A health worker attends to an mpox patient, at a treatment center in Munigi, eastern Congo, Aug. 19, 2024. Credit: AP Photo\/Moses Sawasawa, File\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>L&rsquo;Organisation mondiale de la sant\u00e9 a annonc\u00e9 vendredi avoir accord\u00e9 sa premi\u00e8re autorisation d&rsquo;utilisation d&rsquo;un vaccin contre le mpox chez les adultes, qualifiant cela d&rsquo;\u00e9tape importante dans la lutte contre la maladie en Afrique et au-del\u00e0.<\/p>\n<p>La pr\u00e9qualification du vaccin par Bavarian Nordic A\/S signifie que des donateurs comme GAVI et l&rsquo;UNICEF peuvent l&rsquo;acheter. Mais les stocks sont limit\u00e9s car il n&rsquo;y a qu&rsquo;un seul fabricant.<\/p>\n<p>\u00ab Cette premi\u00e8re pr\u00e9-qualification d&rsquo;un vaccin contre le mpox est une \u00e9tape importante dans notre lutte contre la maladie, \u00e0 la fois dans le contexte des \u00e9pid\u00e9mies actuelles en Afrique, et \u00e0 l&rsquo;avenir \u00bb, a d\u00e9clar\u00e9 le directeur g\u00e9n\u00e9ral de l&rsquo;OMS, Tedros Adhanom Ghebreyesus.<\/p>\n<p>Le chef de l&rsquo;agence de sant\u00e9 des Nations Unies a appel\u00e9 \u00e0 une intensification \u00ab urgente \u00bb des achats, des dons et du d\u00e9ploiement pour acheminer le vaccin l\u00e0 o\u00f9 il est le plus n\u00e9cessaire, ainsi qu&rsquo;\u00e0 d&rsquo;autres mesures de r\u00e9ponse.<\/p>\n<p>En vertu de l&rsquo;autorisation de l&rsquo;OMS, le vaccin peut \u00eatre administr\u00e9 aux personnes \u00e2g\u00e9es de 18 ans ou plus, dans le cadre d&rsquo;un sch\u00e9ma \u00e0 deux doses. L&rsquo;approbation pr\u00e9cise que m\u00eame si le vaccin n&rsquo;est pas actuellement autoris\u00e9 pour les moins de 18 ans, il peut \u00eatre utilis\u00e9 chez les nourrissons, les enfants et les adolescents \u00ab dans les situations d&rsquo;\u00e9pid\u00e9mie o\u00f9 les avantages de la vaccination l&#8217;emportent sur les risques potentiels \u00bb.<\/p>\n<p>Les responsables du Centre africain de contr\u00f4le et de pr\u00e9vention des maladies ont d\u00e9clar\u00e9 le mois dernier que pr\u00e8s de 70 % des cas au Congo, le pays le plus touch\u00e9 par le mpox, concernent des enfants de moins de 15 ans, qui repr\u00e9sentent \u00e9galement 85 % des d\u00e9c\u00e8s.<\/p>\n<p>Jeudi, le CDC Afrique a d\u00e9clar\u00e9 que 107 nouveaux d\u00e9c\u00e8s et 3 160 nouveaux cas avaient \u00e9t\u00e9 enregistr\u00e9s au cours de la semaine \u00e9coul\u00e9e, juste une semaine apr\u00e8s que lui et l&rsquo;OMS ont lanc\u00e9 un plan de r\u00e9ponse continental.<\/p>\n<p>La variole appartient \u00e0 la m\u00eame famille de virus que la variole, mais provoque des sympt\u00f4mes plus l\u00e9gers comme de la fi\u00e8vre, des frissons et des courbatures. Les personnes atteintes de cas plus graves peuvent d\u00e9velopper des l\u00e9sions sur le visage, les mains, la poitrine et les parties g\u00e9nitales.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>L&rsquo;Organisation mondiale de la sant\u00e9 a annonc\u00e9 vendredi avoir accord\u00e9 sa premi\u00e8re autorisation d&rsquo;utilisation d&rsquo;un<\/p>\n","protected":false},"author":1,"featured_media":345,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[306,321,327,320,248,324,8,322,325,326,323],"class_list":["post-344","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-afrique","tag-approuve","tag-audela","tag-loms","tag-maladie","tag-mpox","tag-pour","tag-premier","tag-renforcer","tag-reponse","tag-vaccin","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0 - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0 - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"L&rsquo;Organisation mondiale de la sant\u00e9 a annonc\u00e9 vendredi avoir accord\u00e9 sa premi\u00e8re autorisation d&rsquo;utilisation d&rsquo;un\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-13T13:02:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-13T13:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"L&rsquo;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0\",\"datePublished\":\"2024-09-13T13:02:29+00:00\",\"dateModified\":\"2024-09-13T13:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\"},\"wordCount\":418,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg\",\"keywords\":[\"Afrique\",\"approuve\",\"audel\u00e0\",\"LOMS\",\"maladie\",\"MPOX\",\"pour\",\"premier\",\"renforcer\",\"r\u00e9ponse\",\"vaccin\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\",\"name\":\"L'OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0 - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg\",\"datePublished\":\"2024-09-13T13:02:29+00:00\",\"dateModified\":\"2024-09-13T13:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"L'OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L&rsquo;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0 - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/","og_locale":"fr_FR","og_type":"article","og_title":"L'OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0 - RVH-Synergie.org","og_description":"L&rsquo;Organisation mondiale de la sant\u00e9 a annonc\u00e9 vendredi avoir accord\u00e9 sa premi\u00e8re autorisation d&rsquo;utilisation d&rsquo;un","og_url":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/","og_site_name":"RVH-Synergie","article_published_time":"2024-09-13T13:02:29+00:00","article_modified_time":"2024-09-13T13:02:41+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"L&rsquo;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0","datePublished":"2024-09-13T13:02:29+00:00","dateModified":"2024-09-13T13:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/"},"wordCount":418,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg","keywords":["Afrique","approuve","audel\u00e0","LOMS","maladie","MPOX","pour","premier","renforcer","r\u00e9ponse","vaccin"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/","url":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/","name":"L'OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0 - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg","datePublished":"2024-09-13T13:02:29+00:00","dateModified":"2024-09-13T13:02:41+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1726232549_LOMS-approuve-le-premier-vaccin-MPOX-pour-renforcer-la-reponse-scaled.jpg","width":2560,"height":1707,"caption":"L'OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/loms-approuve-le-premier-vaccin-mpox-pour-renforcer-la-reponse-a-la-maladie-en-afrique-et-au-dela\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"L&rsquo;OMS approuve le premier vaccin MPOX pour renforcer la r\u00e9ponse \u00e0 la maladie en Afrique et au-del\u00e0"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=344"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/344\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/345"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}